Pfizer shares are trading higher after a German court suspended a patent trial against BioNTech by CureVac.
Portfolio Pulse from Bill Haddad
Pfizer shares are trading higher following the suspension of a patent trial against BioNTech by CureVac in a German court.
September 29, 2023 | 6:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pfizer's stock price is trading higher due to the suspension of a patent trial against BioNTech by CureVac.
The suspension of the patent trial against BioNTech by CureVac is positive news for Pfizer, as it reduces potential legal risks and uncertainties. This has led to an increase in Pfizer's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100